| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.CARPATH.2014.12.001 |
| P698 | PubMed publication ID | 25547609 |
| P2093 | author name string | Suhail Al-Salam | |
| Satwat Hashmi | |||
| P433 | issue | 4 | |
| P921 | main subject | myocardial infarction | Q12152 |
| P304 | page(s) | 213-223 | |
| P577 | publication date | 2014-12-09 | |
| P1433 | published in | Cardiovascular Pathology | Q1992658 |
| P1476 | title | Galectin-3 is expressed in the myocardium very early post-myocardial infarction. | |
| P478 | volume | 24 |
| Q36095060 | Acute myocardial infarction and myocardial ischemia-reperfusion injury: a comparison |
| Q92977975 | Association between new circulating proinflammatory and anti-inflammatory adipocytokines with coronary artery disease |
| Q93261783 | Echocardiographic diastolic function evolution in patients with an anterior Q-wave myocardial infarction: insights from the REVE-2 study |
| Q64996975 | Galectin 3 and Galectin 3 Binding Protein Improve the Risk Stratification after Myocardial Infarction. |
| Q35919323 | Galectin-1: a biomarker of surgical stress in murine model of cardiac surgery |
| Q90073141 | Galectin-3 as a Next-Generation Biomarker for Detecting Early Stage of Various Diseases |
| Q33754984 | Galectin-3 in Peripheral Artery Disease. Relationships with Markers of Oxidative Stress and Inflammation. |
| Q37707674 | Galectin-3 inhibition ameliorates hypoxia-induced pulmonary artery hypertension |
| Q39019273 | Immunohistochemical detection of early myocardial infarction: a systematic review |
| Q59189096 | Left ventricular remodeling after the first myocardial infarction in association with LGALS-3 neighbouring variants rs2274273 and rs17128183 and its relative mRNA expression: a prospective study |
| Q49835908 | Molecular tissue changes in early myocardial ischemia: from pathophysiology to the identification of new diagnostic markers. |
| Q88104918 | Multiplex quantitative imaging of human myocardial infarction by mass spectrometry-immunohistochemistry |
| Q91594685 | Myocardial Injury After Ischemia/Reperfusion Is Attenuated By Pharmacological Galectin-3 Inhibition |
| Q38729745 | TAM receptor tyrosine kinase function and the immunopathology of liver disease |
| Q48141318 | Ticagrelor attenuates myocardial ischemia-reperfusion injury possibly through downregulating galectin-3 expression in the infarct area of rats |
| Q47677252 | Understanding cardiac extracellular matrix remodeling to develop biomarkers of myocardial infarction outcomes. |
Search more.